Home   |   Donate   |   Industry   |   Print Page   |   Your Cart   |   Sign In   |   Join Now
Keyword Search
News & Press: Latest News

FDA calls for comments from the public on two drugs developed to treat gut motility disorders

Thursday, October 4, 2018   (0 Comments)
Posted by: Cathy Harrington
Share |

Two meetings are scheduled and posted in the Federal Registry to review drug applications.  It is standard practice to hold an open comment period and solicit input from the public. This is an excellent opportunity for people to share their stories and struggles with the two disorders that these drugs have been developed to treat. Comments help the committee understand how living and struggling with these particular disorders can impact daily life.  

 

Be sure to note the deadlines for submitting your comments.

 

Zelnorm-- https://www.fda.gov/AdvisoryCommittees/Calendar/ucm620341.htm 

 

Prucalopride-- https://www.fda.gov/AdvisoryCommittees/Calendar/ucm620357.htm 

 

Please do not hesitate to contact us with any questions.

 

Joan Bishop

Executive Director
(518) 262-5079

bishopj@amc.edu

This website is an educational resource. It is not intended to provide medical advice or recommend a course of treatment. You should discuss all issues, ideas, suggestions, etc. with your clinician prior to use. Clinicians in a relevant field have reviewed the medical information; however, the Oley Foundation does not guarantee the accuracy of the information presented, and is not liable if information is incorrect or incomplete. If you have questions please contact Oley staff.

 

Updated in 2015 with a generous grant from Shire, Inc. 

 

This website was updated in 2015 with a generous grant from Shire, Inc. This website is an educational resource. It is not intended to provide medical advice or recommend a course of treatment. You should discuss all issues, ideas, suggestions, etc. with your clinician prior to use. Clinicians in a relevant field have reviewed the medical information; however, the Oley Foundation does not guarantee the accuracy of the information presented, and is not liable if information is incorrect or incomplete. If you have questions please contact Oley staff.
Membership Management Software Powered by YourMembership  ::  Legal